Streamline AAV-based Gene Therapies with High-Performing Off-the-Shelf Plasmids

Optimized plasmids are vital for viral vector production. Catalent’s off-the-shelf plasmids help AAV gene therapy developers enhance efficiency, reduce costs, and improve consistency across development and manufacturing.